The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients.

Ahmed El-GhandourTarek YoussifWesam IbrahimHoda Ahmed AbdelsattarSomia Abd Elhamid BawadyMariam WagihSarah El-Nakeep

Published in: The Egyptian journal of internal medicine (2023)

DAAs affect the metabolic profile of the treated patients. There is a noticed improvement in the FibroScan, NAFLD score, and lipid profile after achieving the SVR-12 weeks. However, LDL is increased after viral cure, mostly due to viral-host molecular interaction.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
peritoneal dialysis
patient reported